शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans
DEEPAKNTRNSEDeepak Nitrite Limited· Chemicals & PetrochemicalsHighNeutral
Announced Wed, 12 Nov, 2025 · 18:29 IST

Deepak Nitrite Q2 FY26: Net profit declines 42% on consolidated basis

Revenue declinedEBITDA margin compressionResults View source PDFExplain this filing

DEEPAKNTR · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-0.5%Reaction day
₹1728.30
prior close
₹1705.00
announcement price
After-mkt
timing
Nifty Smallcap 250market · index membership as recorded later (tracked since Jun 2026)-0.4%-0.1% vs market
Specialty Chemicals peers, median of 86sector-0.3%-0.2% vs sector

On the reaction day the stock moved 0.1 pts less than Nifty Smallcap 250 and 0.2 pts less than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+0.4
10m
+0.6
15m
+0.5
30m
+0.2
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-0.5-0.4-0.1-0.3-0.2
Next day
+0.9-0.2+1.1-0.8+1.7
2d
+0.1+0.5-0.4-1.0+1.1
3d
-1.0-0.6-0.4-2.4+1.4
4d
-1.3-1.0-0.3-3.3+2.0
5d
-1.2-1.1-0.1-3.1+1.9
1w
-6.1-2.9-3.1-4.9-1.2
15d
-11.5-3.1-8.3-5.9-5.5
1m
-9.0-3.9-5.1-6.3-2.7
2m
-9.0-5.3-3.6-10.6+1.6
3m
-5.5-6.6+1.2-11.6+6.1
UpDownMarket · Nifty Smallcap 250Sector · Specialty Chemicals peers, median of 86Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Consolidated revenue from operations fell to 3,791.77 Cr from 4,198.84 Cr, down about 9.7% year on year. Net profit dropped to 231.01 Cr from 396.73 Cr, a fall of about 41.8%. Standalone net profit declined to 141.95 Cr from 205.33 Cr, down about 30.9%. Standalone revenue was 1,228.20 Cr versus 1,320.41 Cr. Profit compression was much sharper than the revenue slide, pointing to margin pressure. Standalone other income includes 91 Cr dividend from subsidiary Deepak Phenolics. Limited review report by Deloitte Haskins and Sells LLP is clean, with no qualifications.

Likely market impact

Sharp fall in profits versus milder revenue dip points to margin compression; shares may react negatively. Clean auditor review limits governance concerns.